The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.

Lupus often presents with skin rashes that doctors rely on for diagnosis. However, these rashes can appear very differently on darker skin tones. In this video, a doctor explains how traditional ...

Researchers have figured out how psoriasis can quietly turn into joint disease for some patients. Immune cells formed in ...

Shingles is a painful blistering rash caused by the chickenpox virus that can last for weeks, months, or even years, and can ...

AstraZeneca has hit what appears to be a minor speed bump in gaining clearance in the U.S. for its subcutaneous (SC) version of lupus treatment Saphnelo. | AstraZeneca will have to negotiate what ...

Biogen’s litifilimab has received Breakthrough Therapy Designation from the US FDA to treat cutaneous lupus erythematosus ...

The Lupus Research Alliance applauds the decision by the U.S. Food and Drug Administration (FDA) to grant Breakthrough Therapy designation for litifilimab (BIIB059) in clinical development by Biogen ...

Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed improvements in cutaneous lupus erythematosus (CLE) skin disease activityLitifil ...

This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.

Lindsay Thompson has rocked it all – from relaxed hair to natural hair – and then the day came when she decided to go bald.